Carolyn Edwards

King's College London — United Kingdom

Medicine · Health Sciences

11h-index2.3kcitations27works7.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Mosquito-borne diseases and control(7), Viral Infections and Vectors(6), Cancer Immunotherapy and Biomarkers(4), Monoclonal and Polyclonal Antibodies Research(4), Virology and Viral Diseases(4)

Publications27 total

Training Senior Wellbeing Practitioners: the development of a framework to identify and assess clinical competency
The Cognitive Behaviour Therapist·2025Open Access
PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets
EMBO Molecular Medicine·2024· 14 citedOpen Access
PD-1/LAG-3 Dysfunctionality Signatures in Human Cancers
2023· 1 citedOpen Access
The multi-specific VH-based Humabody CB213 co-targets PD1 and LAG3 on T cells to promote anti-tumour activity
British Journal of Cancer·2021· 17 citedOpen Access
Abstract 930: CB213: A half-life extended bispecific Humabody VH delivering dual checkpoint blockade to reverse the dysfunction of LAG3+PD-1+ double-positive T cells
Cancer Research·2020· 10 cited
Diverse human VH antibody fragments with bio-therapeutic properties from the Crescendo Mouse
New Biotechnology·2019· 29 citedOpen Access
Abstract 565: A novel T-cell costimulatory Humabody® VH therapeutic for PSMA-positive tumors
Cancer Research·2019
G103 That’s what chums are for – benefits of a medical student paediatric volunteering service
2018Open Access
How sharing your medical data could save your life
Engineering & Technology·2017
Erratum: Corrigendum: A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus
Nature Immunology·2015· 20 citedOpen Access
Erratum: Corrigendum: A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus
Nature Immunology·2015· 4 cited
A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus
Nature Immunology·2014· 491 citedOpen Access
High-Avidity and Potently Neutralizing Cross-Reactive Human Monoclonal Antibodies Derived from Secondary Dengue Virus Infection
Journal of Virology·2013· 103 citedOpen Access
Potent and broad neutralization of HIV-1 by a llama antibody elicited by immunization
The Journal of Experimental Medicine·2012· 112 citedOpen Access
Immunopathogenesis of Dengue Haemorrhagic Fever
Spiral (Imperial College London)·2011· 6 citedOpen Access
Sharing what we know
Engineering & Technology·2010· 2 cited
Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
Science·2010· 920 cited
Molecular diagnosis and analysis of Chikungunya virus
Journal of Clinical Virology·2007· 128 cited
Is the MMR vaccine safe?
Western Journal of Medicine·2001· 5 citedOpen Access
Student soapbox: keeping clean
BMJ·2000· 1 cited
page 1 of 2Next →

Frequent Co-authors

Amonrat Jumnainsong(5), Juthathip Mongkolsapaya(5), Gavin Screaton(5), James Legg(5), Wanwisa Dejnirattisai(4), Thaneeya Duangchinda(4), Sunpetchuda Supasa(4), Prida Malasit(4), Wei‐Kung Wang(4), Yumin Teng(4), Miren Zuazo(4), Hugo Arasanz(4), Ana Bocanegra(4), Grazyna Kochan(4), David Escors(4), Wiyada Wongwiwat(3), Xinghong Dai(3), Nguyen Than Ha Quyen(3), Jonathan M. Grimes(3), Jeremy Farrar(3)